Earlier this month, Medical imaging and radiographics diagnostic innovator OXOS Medical announced a $23 million Series A funding round co-led by Parkway Venture Capital and Intel Capital. According to OXOS, this brings its funding raised total to $45 million.
From OXOS’ own media release,
“OXOS will use the funding to accelerate product innovation and expand availability globally” for its small form factor, high resolution imaging technology.
“We believe OXOS will have the same transformational impact on radiology as the iPhone had on mobile computing,” shared Gregg Hill, Parkway Venture Capital managing partner.
Founded in 2016 and based in Atlanta, OXOS was a presenting company in PitchRounds at AdvanSE 2022.
Over the course of Southeast Life Science’s history, including the combined entities of the Southeastern Medical Device Association and SE BIO, more than 500 presenting companies have raised nearly $8 billion through 800 funding transactions.
Late last year, fellow AdvanSE presenting alumni Acclinate and Embody announced $4.9 million and $10.4 million rounds respectively.
Images credit: OXOS Medical